Abstract
Captopril was administered to three groups of hypertensive children and adolescents: 1) patients with renal disease; 2) neonates with umbilical artery related hypertension; and 3) post-renal transplant patients. In older children with renal disease, increasing the captopril dose above 0.5 mg/kg did not improve the antihypertensive response. A maximal drug concentrations occurred one hour after dosing, and captopril concentration returned to predose levels by eight hours. Neonates responded to significantly lower doses of captopril (0.01-0.5 mg/kg) and the duration of response to higher doses appeared to be longer than that observed in older children. In post-renal transplant patients, blood pressure decreased after captopril in 94% of subjects, but in 62% a concomitant increase in serum creatinine was observed (correlation [r]=0.55, p<02). This increase could not be correlated with renal biopsy histopathology. Thus, captopril has proven to be an effective antihypertensive agent in children over a broad age range and for a variety of clinical conditons.
Original language | English (US) |
---|---|
Pages (from-to) | 829-839 |
Number of pages | 11 |
Journal | Clinical and Experimental Hypertension |
Volume | 8 |
Issue number | 4-5 |
DOIs | |
State | Published - Jan 1 1986 |
Keywords
- Blood pressure
- Captopril
- Drug disposition
- Newborn
- Renal disease
- Renal transplant